SEC Form 4 · accession 0001144204-17-015198
Synthetic Biologics, Inc. · SYN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey J Kraws
Director
Period of report
Mar 14, 2017
Accepted (ET)
Mar 16, 2017 · 6:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000894158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 14, 2017 | M | 228,773 | $0.09 | A | 228,773 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $0.09 | Mar 14, 2017 | M | 228,773 | D | Jan 1, 2006 | Mar 20, 2017 | Common Stock | 228,773 | 0 | D |
Explanation of responses
- F1Reflects a 1-for-3 reverse stock split effected in 2007.